The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.5% between 2025 ...

Diabetic retinopathy is a common complication of diabetes (including type 2 diabetes) that causes vision problems. By controlling your blood sugar, blood pressure, and cholesterol, you can reduce your ...

Dr. Mohan’s Diabetes Specialities Centre (DMDSC) on Tuesday launched an AI-driven software to detect diabetic retinopathy at its Thanjavur Centre. The ‘Diabetic Retinopathy Software’ seeks ...

There are several systemic health risks associated with diabetes, such as heart disease, chronic kidney disease and diabetic retinopathy (DR). While other risks often present with symptoms ...

AIM To determine the staining pattern of vascular endothelial growth factor (VEGF) at different stages of diabetic retinopathy (including post-laser photocoagulation) and to compare staining in ...

It is currently scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy. The system, called the LumineticsCore ...

Introduction Diabetic retinopathy is one of the leading causes of vision impairment globally. Alongside the systemic control of diabetes and timely detection of diabetic retinopathy, the prompt ...

Background: Diabetic retinopathy, a major microvascular complication of diabetes, significantly contributes to global blindness. Emerging evidence suggests a potential association between depression ...

Credit: SUPERMAO/Shutterstock. Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat non-proliferative diabetic retinopathy (NPDR). The ...